459 related articles for article (PubMed ID: 33749332)
1. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast-derived NOTUM reduces cortical bone mass in mice and the
Movérare-Skrtic S; Nilsson KH; Henning P; Funck-Brentano T; Nethander M; Rivadeneira F; Coletto Nunes G; Koskela A; Tuukkanen J; Tuckermann J; Perret C; Souza PPC; Lerner UH; Ohlsson C
FASEB J; 2019 Oct; 33(10):11163-11179. PubMed ID: 31307226
[TBL] [Abstract][Full Text] [Related]
3. Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.
Kao RS; Abbott MJ; Louie A; O'Carroll D; Lu W; Nissenson R
Bone; 2013 Aug; 55(2):277-87. PubMed ID: 23583750
[TBL] [Abstract][Full Text] [Related]
4. Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in Osteocytes.
Alam I; Reilly AM; Alkhouli M; Gerard-O'Riley RL; Kasipathi C; Oakes DK; Wright WB; Acton D; McQueen AK; Patel B; Lim KE; Robling AG; Econs MJ
Calcif Tissue Int; 2017 Apr; 100(4):361-373. PubMed ID: 28013361
[TBL] [Abstract][Full Text] [Related]
5. Notum Deletion From Late-Stage Skeletal Cells Increases Cortical Bone Formation and Potentiates Skeletal Effects of Sclerostin Inhibition.
Choi RB; Bullock WA; Hoggatt AM; Horan DJ; Pemberton EZ; Hong JM; Zhang X; He X; Robling AG
J Bone Miner Res; 2021 Dec; 36(12):2413-2425. PubMed ID: 34223673
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice.
Windahl SH; Börjesson AE; Farman HH; Engdahl C; Movérare-Skrtic S; Sjögren K; Lagerquist MK; Kindblom JM; Koskela A; Tuukkanen J; Divieti Pajevic P; Feng JQ; Dahlman-Wright K; Antonson P; Gustafsson JÅ; Ohlsson C
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2294-9. PubMed ID: 23345419
[TBL] [Abstract][Full Text] [Related]
7. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
[TBL] [Abstract][Full Text] [Related]
8. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
[TBL] [Abstract][Full Text] [Related]
9. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.
Canalis E; Adams DJ; Boskey A; Parker K; Kranz L; Zanotti S
J Biol Chem; 2013 Aug; 288(35):25614-25625. PubMed ID: 23884415
[TBL] [Abstract][Full Text] [Related]
11. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice.
Xiao Z; Dallas M; Qiu N; Nicolella D; Cao L; Johnson M; Bonewald L; Quarles LD
FASEB J; 2011 Jul; 25(7):2418-32. PubMed ID: 21454365
[TBL] [Abstract][Full Text] [Related]
12. Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization.
Lewis KJ; Choi RB; Pemberton EZ; Bullock WA; Firulli AB; Robling AG
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505764
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and RSPO3 regulate vertebral trabecular bone mass independent of each other.
Nilsson KH; Wu J; Gustafsson KL; El Shahawy M; Koskela A; Tuukkanen J; Tuckermann J; Henning P; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E211-E218. PubMed ID: 35068191
[TBL] [Abstract][Full Text] [Related]
14. Inducible
Ohlsson C; Henning P; Nilsson KH; Wu J; Gustafsson KL; Sjögren K; Törnqvist A; Koskela A; Zhang FP; Lagerquist MK; Poutanen M; Tuukkanen J; Lerner UH; Movérare-Skrtic S
J Endocrinol; 2018 May; 237(2):113-122. PubMed ID: 29530924
[TBL] [Abstract][Full Text] [Related]
15. Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification.
Alioli CA; Demesmay L; Laurencin-Dalacieux S; Beton N; Farlay D; Follet H; Saber A; Duboeuf F; Chun J; Rivera R; Bouvard D; Machuca-Gayet I; Salles JP; Gennero I; Peyruchaud O
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158715. PubMed ID: 32330664
[TBL] [Abstract][Full Text] [Related]
16. Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.
McKenzie J; Smith C; Karuppaiah K; Langberg J; Silva MJ; Ornitz DM
J Bone Miner Res; 2019 Sep; 34(9):1660-1675. PubMed ID: 31206783
[TBL] [Abstract][Full Text] [Related]
17. Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.
Canalis E; Zanotti S; Schilling L; Eller T; Yu J
J Biol Chem; 2021; 296():100583. PubMed ID: 33774049
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.
Movérare-Skrtic S; Henning P; Liu X; Nagano K; Saito H; Börjesson AE; Sjögren K; Windahl SH; Farman H; Kindlund B; Engdahl C; Koskela A; Zhang FP; Eriksson EE; Zaman F; Hammarstedt A; Isaksson H; Bally M; Kassem A; Lindholm C; Sandberg O; Aspenberg P; Sävendahl L; Feng JQ; Tuckermann J; Tuukkanen J; Poutanen M; Baron R; Lerner UH; Gori F; Ohlsson C
Nat Med; 2014 Nov; 20(11):1279-88. PubMed ID: 25306233
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the auxiliary α2δ1 voltage sensitive calcium channel subunit in osteocytes and late-stage osteoblasts impairs femur strength and load-induced bone formation in male mice.
Wright CS; Lewis KJ; Semon K; Yi X; Reyes Fernandez PC; Rust K; Prideaux M; Schneider A; Pederson M; Deosthale P; Plotkin LI; Hum JM; Sankar U; Farach-Carson MC; Robling AG; Thompson WR
J Bone Miner Res; 2024 Apr; 39(3):298-314. PubMed ID: 38477790
[TBL] [Abstract][Full Text] [Related]
20. Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K/AKT/GSK3β/β-catenin pathway.
Li C; Yang P; Liu B; Bu J; Liu H; Guo J; Hasegawa T; Si H; Li M
J Mol Histol; 2021 Oct; 52(5):1081-1095. PubMed ID: 34297260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
